Literature DB >> 12074319

The Ki-67 index and survival in non-small cell lung cancer: a review and relevance to positron emission tomography.

Jeffrey M Pugsley1, Rodney A Schmidt, Hubert Vesselle.   

Abstract

PURPOSE: We reviewed the current literature to discover the range of studies covering tissue-based and noninvasive methods for determining tumor stage and the prognostic value of staging in non-small cell lung cancer.
DESIGN: Despite refinements in staging of non-small cell lung cancer, each stage remains heterogeneous because each stage contains patients who are at higher risk for recurrence than other patients within the same stage. Tissue-based and noninvasive methods have been investigated to complement tumor stage in assessing non-small cell lung cancer prognosis. The prognostic significance of tumor proliferation assessed by Ki-67 protein expression has been demonstrated in non-small cell lung cancer. RESULT: Recent positron emission tomography studies have also shown both prognostic value in non-small cell lung cancer uptake of [F-18] fluorodeoxyglucose (FDG) and correlation between non-small cell lung cancer FDG uptake and tumor proliferation. DISCUSSION: We reviewed the prognostic significance of Ki-67 expression in non-small cell lung cancer and related it to positron emission tomography.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12074319     DOI: 10.1097/00130404-200205000-00003

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  12 in total

1.  Early evaluation of neoadjuvant chemotherapy response using FDG-PET/CT predicts survival prognosis in patients with head and neck squamous cell carcinoma.

Authors:  Masahiro Kikuchi; Yuji Nakamoto; Shogo Shinohara; Keizo Fujiwara; Hiroshi Yamazaki; Yuji Kanazawa; Risa Kurihara; Ippei Kishimoto; Hiroyuki Harada; Yasushi Naito
Journal:  Int J Clin Oncol       Date:  2012-03-09       Impact factor: 3.402

2.  Examining Nek2 as a better proliferation marker in non-small cell lung cancer prognosis.

Authors:  Xinwen Zhong; Xiaojiao Guan; Qianze Dong; Shize Yang; Wenke Liu; Lin Zhang
Journal:  Tumour Biol       Date:  2014-04-25

3.  Effects of beta-carotene supplementation on molecular markers of lung carcinogenesis in male smokers.

Authors:  Margaret E Wright; Steve D Groshong; Kirsti Husgafvel-Pursiainen; Erin Genova; M Scott Lucia; Henrik Wolff; Jarmo Virtamo; Demetrius Albanes
Journal:  Cancer Prev Res (Phila)       Date:  2010-05-18

4.  Longitudinally quantitative 2-deoxy-2-[18F]fluoro-D-glucose micro positron emission tomography imaging for efficacy of new anticancer drugs: a case study with bortezomib in prostate cancer murine model.

Authors:  Yumin Zhang; Melissa Saylor; Shenhua Wen; Matthew D Silva; Mark Rolfe; Joseph Bolen; Craig Muir; Corinne Reimer; Sudeep Chandra
Journal:  Mol Imaging Biol       Date:  2006 Sep-Oct       Impact factor: 3.488

5.  Clinical significance of Ki-67 and p53 expression in curatively resected non-small cell lung cancer.

Authors:  Hee Kyung Ahn; Minkyu Jung; Seung-Yeon Ha; Jae-Ik Lee; Inkeun Park; Young Saing Kim; Junshik Hong; Sun Jin Sym; Jinny Park; Dong Bok Shin; Jae Hoon Lee; Eun Kyung Cho
Journal:  Tumour Biol       Date:  2014-04-16

6.  [18F]fluoro-2-deoxyglucose-positron emission tomography for the assessment of histopathological response after preoperative chemoradiotherapy in advanced oral squamous cell carcinoma.

Authors:  Hiroyuki Shimomura; Tomonori Sasahira; Yasutsugu Yamanaka; Miyako Kurihara; Yuichiro Imai; Shigehiro Tamaki; Nobuhiro Yamakawa; Norihisa Shirone; Masatoshi Hasegawa; Hiroki Kuniyasu; Tadaaki Kirita
Journal:  Int J Clin Oncol       Date:  2014-06-19       Impact factor: 3.402

7.  Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer.

Authors:  Jun Yang; Nithya Ramnath; Kirsten B Moysich; Harold L Asch; Helen Swede; Sadir J Alrawi; Joel Huberman; Joseph Geradts; John S J Brooks; Dongfeng Tan
Journal:  BMC Cancer       Date:  2006-08-01       Impact factor: 4.430

8.  Ki-67 as a prognostic marker in early-stage non-small cell lung cancer in Asian patients: a meta-analysis of published studies involving 32 studies.

Authors:  Song Wen; Wei Zhou; Chun-Ming Li; Juan Hu; Xiao-Ming Hu; Ping Chen; Guo-Liang Shao; Wu-Hua Guo
Journal:  BMC Cancer       Date:  2015-07-15       Impact factor: 4.430

9.  Toxicology evaluation of radiotracer doses of 3'-deoxy-3'-[18F]fluorothymidine (18F-FLT) for human PET imaging: Laboratory analysis of serial blood samples and comparison to previously investigated therapeutic FLT doses.

Authors:  Eric Turcotte; Linda W Wiens; John R Grierson; Lanell M Peterson; Mark H Wener; Hubert Vesselle
Journal:  BMC Nucl Med       Date:  2007-07-03

10.  Aberrant expression of NEK2 and its clinical significance in non-small cell lung cancer.

Authors:  Xinwen Zhong; Xiaojiao Guan; Wenke Liu; Lin Zhang
Journal:  Oncol Lett       Date:  2014-07-30       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.